Philadelphia, PA, United States of America

Gustavo D Aguirre

USPTO Granted Patents = 15 (Patent Applications = 10)

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Ithaca, NY (US) (1998 - 2012)
Philadelphia, PA (US) (2007 - 2019)
Media, PA (US) (2021)

Company Filing History:

11 out of 1,521

Cornell Research Foundation Inc.

patents

6 out of 2,595

University of Pennsylvania

patents

6 out of 2,925

University of Florida Research Foundation, Incorporated

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12203074 - Compositions and methods for treatment of dominant retinitis pigmentosa (2025-01-21),

2. 11118185 - AAV vectors for treatment of dominant retinitis pigmentosa (2021-09-14),

3. 10383922 - AAV-mediated gene therapy for RPGR X-linked retinal degeneration (2019-08-20),

4. 9770491 - AAV-mediated gene therapy for RPGR X-linked retinal degeneration (2017-09-26),

5. 9433688 - Method of treating or retarding the development of blindness (2016-09-06),

6. 8206911 - Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same (2012-06-26),

7. 8147823 - Method of treating or retarding the development of blindness (2012-04-03),

8. 7811761 - Method for identifying progressive rod-cone degeneration in dogs (2010-10-12),

9. 7723507 - Diagnostic test for Collie Eye Anomaly (2010-05-25),

10. 7671187 - Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same (2010-03-02),

11. 7462455 - Diagnostic test for collie eye anomaly (2008-12-09),

12. 7312037 - Identification of the gene and mutation responsible for progressive rod-cone degeneration in dog and a method for testing same (2007-12-25),

13. 6428958 - Identification of congenital stationary night blindness in dogs (2002-08-06),

14. 6201114 - Identification of congenital stationary night blindness in dogs (2001-03-13),

15. 5804388 - Chromosome 9 and progressive rod-cone degeneration disease genetic (1998-09-08),

Title: Gustavo D Aguirre: Innovator in Retinal Treatment

Introduction

Gustavo D Aguirre is a prominent inventor based in Philadelphia, PA, known for his significant contributions to the field of retinal treatment. With a total of 15 patents, Aguirre has focused on developing innovative methods and compositions aimed at treating dominant retinitis pigmentosa, a genetic disorder that leads to progressive vision loss.

Latest Patents

Aguirre's latest patents include groundbreaking work on "Compositions and methods for treatment of dominant retinitis pigmentosa." This patent outlines methods and compositions useful for treating retinitis pigmentosa by delivering interfering RNA to reduce the expression of mutant RHO alleles associated with the condition. Additionally, he has developed AAV vectors for the same purpose, which also involve delivering a replacement RHO coding sequence resistant to the interfering RNA.

Career Highlights

Throughout his career, Aguirre has worked with esteemed organizations such as the Cornell Research Foundation Inc. and the University of Pennsylvania. His work has significantly advanced the understanding and treatment of retinal diseases, making him a key figure in the field of ophthalmology.

Collaborations

Aguirre has collaborated with notable colleagues, including Gregory M Acland and William W Hauswirth, further enhancing the impact of his research and innovations.

Conclusion

Gustavo D Aguirre's contributions to the treatment of retinal disorders exemplify the importance of innovation in medical science. His work continues to inspire advancements in the field and offers hope to those affected by genetic vision loss.

This text is generated by artificial intelligence and may not be accurate.